All In Biotech

Drug Trial Radar · NCT06463028

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, and a Substudy Evaluating PIKTOR With Paclitaxel Plus an Insulin-Suppressing Diet, in Patients With Advanced or Recurrent Endometrial Cancer

Last checked: Nov 19, 2026Latest source record: Dec 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Dec 12, 2024

Primary completion

Sep 2028

Study completion Sep 2029

Sponsor

Lead sponsor
Faeth TherapeuticsIndustry
Sponsor type
Industry
Collaborators
GOG Foundation
First posted
Jun 17, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial cancer.

Conditions

  • Endometrial Cancer

Interventions

  • SapanisertibDrug

    Oral

  • SerabelisibDrug

    Oral

  • PaclitaxelDrug

    Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR)Time frame: Up to 2 years

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • University of California, San Francisco (UCSF)

    San Francisco, California · Recruiting

  • Mount Sinai Comprehensive Cancer Center

    Miami Beach, Florida · Recruiting

  • Florida Cancer Specialists, North

    St. Petersburg, Florida · Recruiting

  • Florida Cancer Specialists, East

    West Palm Beach, Florida · Recruiting

  • Maryland Oncology Hematology, P.A.

    Brandywine, Maryland · Recruiting

  • Minnesota Oncology Hematology, P.A.

    Maple Grove, Minnesota · Recruiting

  • Women's Cancer Care Associates, LLC

    Albany, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • University of Cincinnati Medical Center

    Cincinnati, Ohio · Recruiting

  • Oncology Associates of Oregon, P.C.

    Eugene, Oregon · Recruiting

  • Northwest Cancer Specialists, P.C.

    Portland, Oregon · Recruiting

  • Alliance Cancer Specialists, PC

    Doylestown, Pennsylvania · Recruiting

  • West Penn Hospital

    Pittsburgh, Pennsylvania · Recruiting

  • Avera Cancer Institute

    Sioux Falls, South Dakota · Recruiting

  • Texas Oncology - West Texas

    El Paso, Texas · Recruiting

  • Texas Oncology - Gulf Coast

    The Woodlands, Texas · Recruiting

  • Virginia Cancer Specialists, P.C.

    Fairfax, Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.